← Eichor
Condition: Patients With Drug Resistant Focal Epilepsy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Patients With Drug Resistant Focal Epilepsy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Dr
Phase 1/Phase 2 · 3 location(s) · NaviFUS Corporation · NCT06388707Biomarkers of Response to SEEG Thermocoagulation
NA · 1 location(s) · Assistance Publique Hopitaux De Marseille · NCT07399327Evaluation of the NaviFUS System in Drug Resistant Epilepsy
NA · 1 location(s) · Genovate-NaviFUS (Australia) Pty Ltd. · NCT05947656A PET-MRI Study of Serotoninergic Brainstem Pathway in Patients With Dravet Syndrome
NA · 1 location(s) · Hospices Civils de Lyon · NCT07013331Links Between Epileptic Activity, Sleep Disruption and Mental Content During Sleep
Phase N/A · 2 location(s) · Hospices Civils de Lyon · NCT07605858Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy
Phase 2 · 10 location(s) · Supernus Pharmaceuticals, Inc. · NCT05518578A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Re
NA · 1 location(s) · NaviFUS Corporation · NCT06492720
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.